These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19664395)

  • 21. Comparative Expression of Apoptotic Markers in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Porębska I; Kosacka M; Sobańska E; Wyrodek E; Jankowska R
    Adv Exp Med Biol; 2015; 873():101-7. PubMed ID: 26022894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients.
    Kim YC; Park KO; Kern JA; Park CS; Lim SC; Jang AS; Yang JB
    Lung Cancer; 1998 Dec; 22(3):181-90. PubMed ID: 10048471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms.
    Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D
    Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.
    Fontanini G; Vignati S; Bigini D; Mussi A; Lucchi M; Angeletti CA; Basolo F; Bevilacqua G
    Br J Cancer; 1995 May; 71(5):1003-7. PubMed ID: 7734290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
    Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
    Shibata Y; Hidaka S; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(3b):1925-8. PubMed ID: 15274378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLF4 expression and apoptosis-related markers in gastric cancer.
    Krstic M; Stojnev S; Jovanovic L; Marjanovic G
    J BUON; 2013; 18(3):695-702. PubMed ID: 24065485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
    Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Chiyo M; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Agamy G; El-Shahhat H; Fujisawa T; Yoshino I
    Eur Respir J; 2009 Jan; 33(1):127-33. PubMed ID: 18715879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
    Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subcellular localization of survivin in non-small cell lung cancer].
    He L; Hou M; Zhang J; Xu N; Chen P
    Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, bcl-2, and p53.
    Cakir E; Yilmaz A; Demirag F; Oguztuzun S; Sahin S; Yazici UE; Aydin M
    APMIS; 2011 Sep; 119(9):574-580. PubMed ID: 21851414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer].
    Zhu ZH; Yang H; Fu JH; Hu Y; Ma Y; Wu QL; Rong TH; Wang DF
    Ai Zheng; 2007 Nov; 26(11):1268-71. PubMed ID: 17991331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study.
    Haque AK; Au W; Cajas-Salazar N; Khan S; Ginzel AW; Jones DV; Zwischenberger JB; Xie J
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):315-22. PubMed ID: 15536330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
    In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma.
    Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V
    Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression features of P-glycoprotein, glutathione S transferase-pi and inhibitor of apoptosis proteins in lymph node metastases of gastrointestinal carcinomas].
    Han J; Tan BB; Wang AF; Lü BR; Geng W; Zhao JH; He CN
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):106-8. PubMed ID: 19563003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.